Sacubitril/valsartan for the management of heart failure: a perspective viewpoint on current evidence

M Volpe, J Bauersachs, A Bayes-Genis, J Butler… - International Journal of …, 2021 - Elsevier
Current international guidelines recommend switching angiotensin converting enzyme
inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) to sacubitril/valsartan (S/V) in …
被引用次数：19 相关文章

Sacubitril/valsartan for the management of heart failure. A perspective viewpoint on current evidence

M Volpe, B Johann, BG Antoni, B Javed… - INTERNATIONAL …, 2020 - iris.uniroma1.it
Current international guidelines recommend switching angiotensin converting enzyme
inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) to sacubitril/valsartan (S/V) in …

Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence

M Volpe, J Bauersachs… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Current international guidelines recommend switching angiotensin converting enzyme
inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) to sacubitril/valsartan (S/V) in …

Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.

M Volpe, J Bauersachs, A Bayés-Genís… - … Journal of Cardiology, 2020 - europepmc.org
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current
evidence. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence

M Volpe, J Bauersachs… - International …, 2021 - internationaljournalofcardiology.com
Current international guidelines recommend switching angiotensin converting enzyme
inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) to sacubitril/valsartan (S/V) in …

Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence

M Volpe, J Bauersachs, A Bayés-Genís… - International Journal …, 2020 - inserm.hal.science
Current international guidelines recommend switching angiotensin converting enzyme
inhibitors (ACE-i) or angiotensin receptor blockers (ARBs) to sacubitril/valsartan (S/V) in …